Medication info
Rabenix Tablet 20 mg (Rabeprazole Sodium)

Rabenix Tablet 20 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
Bionex Co., Ltd.
Appearance
Pale yellow, round enteric-coated tablet
Packaging
28 tablets/PTP
Approval status
Active

MFDS item code 200610980 · Notified 2006.11.20 · Insurance code 643100490

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (Helicobacter pylori eradication), and Zollinger-Ellison syndrome
Who takes it
Adults
Adult dose
Gastric ulcer, duodenal ulcer The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If healing has not occurred after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, administration of 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms have resolved, subsequent symptoms may be controlled with an on-demand regimen of 10 mg once daily as needed. Long-term maintenance therapy for gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication It is recommended that this drug 20 mg be administered in combination with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted according to the needs of each patient, up to 120 mg daily. Doses up to 100 mg may be administered once daily, while the 120 mg dose is divided into 60 mg twice daily.

Ingredients

Manufacturer
Bionex Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (Helicobacter pylori eradication), and Zollinger-Ellison syndrome

  • Gastric ulcers
  • duodenal ulcers
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication helps treat ulcers formed in the stomach and duodenum, and is used to relieve discomfort caused by gastroesophageal reflux disease. It can also be utilized for long-term maintenance therapy to prevent recurrence of symptoms of gastroesophageal reflux disease. For patients with gastrointestinal ulcers associated with Helicobacter pylori infection, it is used in combination with antibiotics to enhance therapeutic effect. It is also effective in conditions of excessive gastric acid secretion, such as Zollinger-Ellison syndrome. It is used to improve and treat various gastrointestinal-related symptoms.

How to take

Adult dose

Gastric ulcer, duodenal ulcer The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If healing has not occurred after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, administration of 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms have resolved, subsequent symptoms may be controlled with an on-demand regimen of 10 mg once daily as needed. Long-term maintenance therapy for gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication It is recommended that this drug 20 mg be administered in combination with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted according to the needs of each patient, up to 120 mg daily. Doses up to 100 mg may be administered once daily, while the 120 mg dose is divided into 60 mg twice daily.

Precautions

This medication should not be administered to patients with specific allergic reactions. Particularly, it should not be used by individuals who are hypersensitive to this drug or its components, or to benzimidazole derivatives in the past. Additionally, when used in conjunction with penicillin-based antibiotics or macrolide antibiotics for the eradication of Helicobacter pylori, it should not be used if there is an allergy to those antibiotics. Patients taking certain medications that can cause serious side effects when used concurrently with this medication should also avoid use, and it is safer not to use this drug for pregnant or breastfeeding women. Patients with impaired liver function or the elderly should be cautious when using this medication, and those with a history of drug hypersensitivity should be administered with care. If symptoms of hypersensitivity such as rash, hives, or itching occur during the use of this medication, it should be discontinued immediately. Routine blood tests are necessary as changes in red or white blood cell counts may occur, and it is recommended to periodically check liver function as well. Various adverse reactions such as cardiac problems, gastrointestinal symptoms, neurological issues, respiratory problems, muscle pain, and skin rash have been reported; therefore, consultation with medical personnel should occur if these symptoms arise. Long-term use of this medication may increase the risk of fractures and can lead to hypomagnesemia, so magnesium levels should be monitored and supplemented as necessary. This medication suppresses gastric acid secretion, which can promote bacterial growth in the gastrointestinal tract; thus, if diarrhea persists or worsens, the possibility of Clostridium difficile infection should be considered. Caution is necessary as drowsiness may occur when driving or operating machinery. This medication may interact with certain drugs; therefore, if taking other medications, it is essential to inform healthcare providers. It is safer not to use this medication during pregnancy or breastfeeding, and safety in children is not established. In cases of overdose, as there is no specific antidote, treatment and supportive therapy according to symptoms are necessary. This medication should not be chewed or crushed but should be swallowed whole. Keep out of reach of children, and do not transfer to another container. Long-term use of this medication may lead to vitamin B12 absorption disorders, so nutritional status should be monitored if necessary. Autoimmune diseases such as skin or systemic lupus erythematosus may present, so if relevant symptoms occur, consult a medical professional immediately. During the administration of this medicine, liver and kidney function, as well as blood status, should be regularly monitored, and if any abnormal signs are found, the treatment should be stopped and appropriate action taken.

Side effects

  • Rash
  • urticaria
  • itching
  • decrease in red blood cells
  • decrease in white blood cells
  • increase in white blood cells
  • increase in eosinophils
  • increase in neutrophils
  • decrease in lymphocytes
  • anemia
Show 164 more
  • petechiae
  • lymphadenopathy
  • hypochromic anemia
  • pancytopenia
  • agranulocytosis
  • thrombocytopenia
  • hemolytic anemia
  • increased ALT
  • increased AST
  • increased ALP
  • increased γ-GTP
  • increased LDH
  • increased total bilirubin
  • fulminant hepatitis
  • liver dysfunction
  • jaundice
  • hypertension
  • myocardial infarction
  • ECG abnormalities
  • migraine
  • syncope
  • angina pectoris
  • heart block
  • palpitations
  • tachycardia
  • bradycardia
  • pulmonary embolism
  • ventricular tachycardia
  • thrombophlebitis
  • vasodilation
  • QTc prolongation
  • ventricular fibrillation
  • diarrhea
  • constipation
  • abdominal pain
  • abdominal bloating
  • dyspepsia
  • belching
  • nausea
  • rectal bleeding
  • bloody stool
  • anorexia
  • cholelithiasis
  • oral ulcer
  • dysphagia
  • gingivitis
  • cholecystitis
  • increased appetite
  • abnormal stool
  • colitis
  • esophagitis
  • glossitis
  • pancreatitis
  • proctitis
  • thirst
  • vomiting
  • lower abdominal pain
  • gastric body
  • gastritis
  • stomatitis
  • taste disorder
  • hemorrhagic diarrhea
  • cholangitis
  • duodenitis
  • gastrointestinal bleeding
  • hepatic encephalopathy
  • hepatitis
  • liver cancer
  • hepatic steatosis
  • salivary gland enlargement
  • thirst
  • headache
  • insomnia
  • anxiety
  • dizziness
  • convulsions
  • abnormal dreams
  • decreased libido
  • neuropathy
  • sensory disturbance
  • tremors
  • weakness
  • neuroexcitation
  • drowsiness
  • vertigo
  • depression
  • restlessness
  • amnesia
  • confusion
  • extrapyramidal syndrome
  • hypervolemia
  • limb weakness
  • sensory impairment
  • decreased grip strength
  • language confusion
  • staggering
  • delirium
  • disorientation
  • somnolence
  • cough
  • pharyngitis
  • rhinitis
  • dyspnea
  • asthma
  • epistaxis
  • laryngitis
  • hiccups
  • hyperventilation
  • bronchitis
  • sinusitis
  • apnea
  • hypoventilation
  • interstitial pneumonia
  • myalgia
  • low back pain
  • arthritis
  • leg cramps
  • bone pain
  • arthropathy
  • bursitis
  • hypertonic muscle syndrome
  • neuralgia
  • single contraction
  • sweating
  • alopecia
  • dry skin
  • shingles
  • psoriasis
  • skin color change
  • toxic epidermal necrolysis
  • mucous membrane syndrome
  • erythema multiforme
  • cataract
  • amblyopia
  • glaucoma
  • dry eyes
  • abnormal vision
  • tinnitus
  • otitis media
  • corneal opacification
  • blurriness
  • double vision
  • hearing loss
  • eye pain
  • retinal degeneration
  • strabismus
  • proteinuria
  • cystitis
  • frequency of urination
  • dysmenorrhea
  • dysuria
  • nephrolithiasis
  • uterine bleeding
  • polyuria
  • gynecomastia
  • increased thyroid-stimulating hormone
  • Clostridium difficile diarrhea
  • systemic lupus erythematosus
  • discoid lupus erythematosus
  • halitosis
  • dry mouth
  • increased intraocular pressure
  • palpitations
  • urinary tract infection

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is best stored at room temperature, between 1 to 30 degrees Celsius. Avoid storing in excessively hot or cold places to help maintain the drug's effectiveness.

Appearance and packaging

Appearance

Pale yellow, round enteric-coated tablet

Package unit

28 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.